Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sterile injectable drugs are sterile, parenteral preparations containing one more Active Pharmaceutical Ingredient (API) intended for administration into the body.
The report details the trend, potential and market size of Sterile Injectable Drugs market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Sterile Injectable Drugsmarket, defines the market attractiveness level of Sterile Injectable Drugs market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Sterile Injectable Drugs industry, describes the types of Sterile Injectable Drugs market, the applications of major players and the market size, and deeply analyzes the current situation of the global Sterile Injectable Drugs market and the development prospects and opportunities of Sterile Injectable Drugs industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Sterile Injectable Drugs market in Chapter 13.
By Player:
Pfizer
Baxter International
Merck
GlaxoSmithKline
Johnson & Johnson
Sanofi
AstraZeneca
Novo Nordisk A/S
Novartis
GILEAD SCIENCES
By Type:
Blood Factors
Cytokines
Peptide Hormone
Immunoglobulin
Monoclonal Antibodies (mAbs)
Insulin
Other Drug Classes
By End-User:
Cancer
Diabetes
Cardiovascular Diseases
Musculoskeletal
CNS
Infections
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Sterile Injectable Drugs Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Sterile Injectable Drugs Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Sterile Injectable Drugs Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Sterile Injectable Drugs Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Sterile Injectable Drugs Market Analysis and Outlook to 2022
-
7.1 Global Sterile Injectable Drugs Consumption (2017-2022)
-
7.2 United States Sterile Injectable Drugs Consumption (2017-2022)
-
7.3 Europe Sterile Injectable Drugs Consumption (2017-2022)
-
7.4 China Sterile Injectable Drugs Consumption (2017-2022)
-
7.5 Japan Sterile Injectable Drugs Consumption (2017-2022)
-
7.6 India Sterile Injectable Drugs Consumption (2017-2022)
-
7.7 South Korea Sterile Injectable Drugs Consumption (2017-2022)
8 Region and Country-wise Sterile Injectable Drugs Market Analysis and Outlook to 2028
-
8.1 Global Sterile Injectable Drugs Consumption Forecast (2022-2028)
-
8.2 United States Sterile Injectable Drugs Consumption Forecast (2022-2028)
-
8.3 Europe Sterile Injectable Drugs Consumption Forecast (2022-2028)
-
8.4 China Sterile Injectable Drugs Consumption Forecast (2022-2028)
-
8.5 Japan Sterile Injectable Drugs Consumption Forecast (2022-2028)
-
8.6 India Sterile Injectable Drugs Consumption Forecast (2022-2028)
-
8.7 South Korea Sterile Injectable Drugs Consumption Forecast (2022-2028)
9 Global Sterile Injectable Drugs Market Outlook by Types and Applications to 2022
-
9.1 Global Sterile Injectable Drugs Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Blood Factors Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Cytokines Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Peptide Hormone Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Monoclonal Antibodies (mAbs) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Insulin Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Other Drug Classes Consumption and Growth Rate (2017-2022)
-
9.2 Global Sterile Injectable Drugs Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Cancer Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Diabetes Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Musculoskeletal Consumption and Growth Rate (2017-2022)
-
9.2.5 Global CNS Consumption and Growth Rate (2017-2022)
-
9.2.6 Global Infections Consumption and Growth Rate (2017-2022)
-
9.2.7 Global Others Consumption and Growth Rate (2017-2022)
10 Global Sterile Injectable Drugs Market Outlook by Types and Applications to 2028
-
10.1 Global Sterile Injectable Drugs Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Blood Factors Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Cytokines Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Peptide Hormone Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Monoclonal Antibodies (mAbs) Consumption Forecast and Growth Rate (2022-2028)
-
10.1.6 Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
10.1.7 Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Sterile Injectable Drugs Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Musculoskeletal Consumption Forecast and Growth Rate (2022-2028)
-
10.2.5 Global CNS Consumption Forecast and Growth Rate (2022-2028)
-
10.2.6 Global Infections Consumption Forecast and Growth Rate (2022-2028)
-
10.2.7 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Sterile Injectable Drugs Import and Export Analysis (Top 5 Countries)
-
11.1 Global Sterile Injectable Drugs Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Sterile Injectable Drugs Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Sterile Injectable Drugs Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Sterile Injectable Drugs Market Competitive Analysis
-
14.1 Pfizer
-
14.1.1 Pfizer Company Details
-
14.1.2 Pfizer Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Pfizer Sterile Injectable Drugs Product and Service
-
14.2 Baxter International
-
14.2.1 Baxter International Company Details
-
14.2.2 Baxter International Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Baxter International Sterile Injectable Drugs Product and Service
-
14.3 Merck
-
14.3.1 Merck Company Details
-
14.3.2 Merck Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Merck Sterile Injectable Drugs Product and Service
-
14.4 GlaxoSmithKline
-
14.4.1 GlaxoSmithKline Company Details
-
14.4.2 GlaxoSmithKline Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 GlaxoSmithKline Sterile Injectable Drugs Product and Service
-
14.5 Johnson & Johnson
-
14.5.1 Johnson & Johnson Company Details
-
14.5.2 Johnson & Johnson Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Johnson & Johnson Sterile Injectable Drugs Product and Service
-
14.6 Sanofi
-
14.6.1 Sanofi Company Details
-
14.6.2 Sanofi Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Sanofi Sterile Injectable Drugs Product and Service
-
14.7 AstraZeneca
-
14.7.1 AstraZeneca Company Details
-
14.7.2 AstraZeneca Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 AstraZeneca Sterile Injectable Drugs Product and Service
-
14.8 Novo Nordisk A/S
-
14.8.1 Novo Nordisk A/S Company Details
-
14.8.2 Novo Nordisk A/S Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Novo Nordisk A/S Sterile Injectable Drugs Product and Service
-
14.9 Novartis
-
14.9.1 Novartis Company Details
-
14.9.2 Novartis Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Novartis Sterile Injectable Drugs Product and Service
-
14.10 GILEAD SCIENCES
-
14.10.1 GILEAD SCIENCES Company Details
-
14.10.2 GILEAD SCIENCES Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 GILEAD SCIENCES Sterile Injectable Drugs Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Sterile Injectable Drugs
-
Figure Sterile Injectable Drugs Picture
-
Table Global Sterile Injectable Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sterile Injectable Drugs Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Sterile Injectable Drugs Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Sterile Injectable Drugs Consumption by Country (2017-2022)
-
Figure United States Sterile Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Table Europe Sterile Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure China Sterile Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Japan Sterile Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure India Sterile Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure South Korea Sterile Injectable Drugs Consumption and Growth Rate (2017-2022)
-
Figure Global Sterile Injectable Drugs Consumption Forecast by Country (2022-2028)
-
Figure United States Sterile Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Sterile Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Sterile Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Sterile Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Sterile Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Sterile Injectable Drugs Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Blood Factors Consumption and Growth Rate (2017-2022)
-
Figure Global Cytokines Consumption and Growth Rate (2017-2022)
-
Figure Global Peptide Hormone Consumption and Growth Rate (2017-2022)
-
Figure Global Immunoglobulin Consumption and Growth Rate (2017-2022)
-
Figure Global Monoclonal Antibodies (mAbs) Consumption and Growth Rate (2017-2022)
-
Figure Global Insulin Consumption and Growth Rate (2017-2022)
-
Figure Global Other Drug Classes Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Consumption and Growth Rate (2017-2022)
-
Figure Global Diabetes Consumption and Growth Rate (2017-2022)
-
Figure Global Cardiovascular Diseases Consumption and Growth Rate (2017-2022)
-
Figure Global Musculoskeletal Consumption and Growth Rate (2017-2022)
-
Figure Global CNS Consumption and Growth Rate (2017-2022)
-
Figure Global Infections Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Blood Factors Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cytokines Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Peptide Hormone Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Immunoglobulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Monoclonal Antibodies (mAbs) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Insulin Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Drug Classes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cancer Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Diabetes Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Cardiovascular Diseases Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Musculoskeletal Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global CNS Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Infections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Sterile Injectable Drugs Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Sterile Injectable Drugs Export by Region (Top 5 Countries) (2017-2028)
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Sterile Injectable Drugs Product and Service
-
Table Baxter International (Foundation Year, Company Profile and etc.)
-
Table Baxter International Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Baxter International Sterile Injectable Drugs Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Sterile Injectable Drugs Product and Service
-
Table GlaxoSmithKline (Foundation Year, Company Profile and etc.)
-
Table GlaxoSmithKline Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GlaxoSmithKline Sterile Injectable Drugs Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Sterile Injectable Drugs Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Sterile Injectable Drugs Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Sterile Injectable Drugs Product and Service
-
Table Novo Nordisk A/S (Foundation Year, Company Profile and etc.)
-
Table Novo Nordisk A/S Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novo Nordisk A/S Sterile Injectable Drugs Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Sterile Injectable Drugs Product and Service
-
Table GILEAD SCIENCES (Foundation Year, Company Profile and etc.)
-
Table GILEAD SCIENCES Sterile Injectable Drugs Sales, Price, Value and Gross Profit (2017-2022)
-
Table GILEAD SCIENCES Sterile Injectable Drugs Product and Service
-
